Abstract

Intravascular hemolysis occurs in many hematologic disorders which results in free hemoglobin (Hb). Haptoglobin (Hp) is an acute-phase plasma glycoprotein that binds free Hb to prevent its oxidative damages. Due to the safety issues related to the plasma-derived proteins, the production of Hp using recombinant DNA technology is considered as an alternative source. In this study, Hp gene was isolated from HepG2 cell line and cloned into pcDNA3.1(+) vector. Gene cloning was confirmed with colony PCR, restriction digestion and DNA sequencing. CHO cells were transfected with the construct, and finally a stable CHO cell line expressing human recombinant Hp (rHp) was established. The expression of rHp was confirmed with RT-PCR and Western blot analyses both at mRNA and protein levels. This is the first report of establishing a stable CHO cell line expressing human rHp as a primary step toward future rHp clinical applications.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.